Hospitals are contemplating financial incentives—as in fines or less support—for patients who could have signed up for health insurance but opted not to.
The program has yet to reach magnet status among cheaper, youthful patients.
HHS has bought airtime in markets with high numbers of uninsured patients.
The White House has until Friday to issue a response to a Supreme Court injunction that temporarily eased birth-control coverage requirements.
Coverage is required, but the new year kicks off with new patients and a lot of loose ends.
A recent government forecast shows the Affordable Care Act is expected to give drugmakers a boost that will grow over time.
The HHS Secretary has some positive enrollment stats to share, but sentiment shows she and Obama need some reputation rehab.
The president says current subscribers will be able to keep their plans.
Site fixes are reported to lag, but CMS plans on inviting consumers to give Healthcare.gov another go.
Official numbers are pending, but Reuters notes enrollment appears to be just 3% of the government's goal.
The Centers for Medicare and Medicaid Services won't say if the change is connected to Healthcare.gov's bumpy launch.
General support for the legislation is up, despite Healthcare.gov woes.
They're not hiding their love or disdain for reform, including one who says the law brings bias into the exam room.
Subscribers will be able to use co-pay cards on Obamacare exchanges.
Five percent of the patient population accounts for 50% of US healthcare costs, one deep dive shows. A major problem: access to medical care.
The short answer: we're not financially prepared for a slowly aging, healthy population, according to a recently published analysis.
Approvals and reviews continue—for now—despite government shutdown.
A roundup of some exchange-related news circling the web.
Growing client demand encouraged the agency to make its HCP content capabilities official.
The midnight shutdown put 800,000 government employees on leave, including those at the FDA, NIH and CDC.
Congress continues to war over healthcare reform. Exchanges will be able to take on members even if the government closes up shop.
Sanofi's PCSK9 agent receives high praise from analysts, Consumer Reports analyzes healthcare reform, Congressional committees propose compounding legislation, NIH funds genomic research.
Despite a possible government standoff, exchanges are coming, as is a proffered rebrand; Amgen signs a university deal in China; Pakistan seeks to rein in pharma; digital marketing is on the rise, research shows
Researchers says growth will average 5.8% a year between 2012 and 2022. They also anticipate generics will hit a leveling-off point that will drive average Rx prices upwards
Sanofi has to provide more Aubagio data to the UK's NICE; healthcare reform's sixes and sevens; NIH puts money toward Alzheimer's research
Biogen extend Isis relationship for six years and $100M; HHS readies healthcare reform TV push; Medivir ends hep. B clinical trial; FDA approves Celgene cancer drug; Baxter seeks Enbrel biosimilar
Benefits research studies show employers expect to lay out 7% more in healthcare costs in 2014, a move that has not been accompanied by lower employee costs.
Takeda moves an Alzheimer's treatment to Phase III; Sangamo acquires Ceregene; Catalyst gets breakthrough designation for auto-immune disorder drug; study says seniors likely to opt out of health insurance
Eli Lilly is accused of misconduct in China, Health and Human Services tries to get young adults interested in health insurance, Novo kid-friendly insulin pen approved; India biotech says its Herceptin biosimilar will launch this year.
Allergan asks FDA to reconsider Restatis generics requirements, Incyte's Jakafi could be pancreatic cancer nemesis, Medtronic says its strategy is at the heart of where healthcare is going and Aetna's app alliance makes health local and personal.